The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Muted movement reflects consolidation phase as investors await earnings triggers
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
The national platform brought together healthcare professionals, patient advocates, and stakeholders
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms
Former Wavemaker executive to lead media strategy and digital transformation agenda
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Subscribe To Our Newsletter & Stay Updated
